Steven P. James serves as Executive at Cascadian Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Steven P. James has executed 15 insider transactions totaling $858.3K, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 28, 2021 involved selling 4,000 shares valued at $432.5K.
Steven P. James currently holds 4,000 shares of Cascadian Therapeutics, Inc. (CASC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Steven P. James has been a net seller of CASC stock. They have purchased $0 and sold $858.3K worth of shares.
Steven P. James's most recent insider trade was on Sep 28, 2021, when they sold 4,000 shares at $108.12 per share.
Get notified when new Form 4 filings are submitted
| $0.53 |
| Discretionary |
| Mar 16, 2021 | ALLK | $425.8K | Sale | 3,500 | $121.65 | Discretionary |
| Mar 16, 2021 | ALLK | $1.9K | Option Exercise | 3,500 | $0.53 | Discretionary |
| Mar 9, 2018 | CASC | $0 | Tender | 13,677 | $N/A | Discretionary |
| Dec 11, 2017 | OCRX | $19.0K | Disposition | 12,500 | $1.52 | Discretionary |
| Sep 24, 2017 | CASC | $2.3K | Payment | 594 | $3.94 | Discretionary |
| Sep 24, 2017 | CASC | $0 | Option Exercise | 2,375 | $N/A | Discretionary |
| Jun 24, 2017 | CASC | $8.6K | Payment | 2,265 | $3.78 | Discretionary |
| Jun 24, 2017 | CASC | $0 | Option Exercise | 9,058 | $N/A | Discretionary |
| Jun 20, 2017 | OCRX | $0 | Award | 12,500 | $N/A | Discretionary |
| Jun 12, 2017 | CASC | $0 | Option Exercise | 2,148 | $N/A | Discretionary |
| Jun 12, 2017 | CASC | $1.8K | Payment | 537 | $3.34 | Discretionary |
| Mar 12, 2017 | CASC | $0 | Option Exercise | 4,656 | $N/A | Discretionary |
| Mar 12, 2017 | CASC | $5.1K | Payment | 1,164 | $4.35 | Discretionary |